SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,394,608 covering the company’s FilmArray ...

血流感染是一种对时间高度敏感的诊断；然而，农村和偏远地区巨大的地理距离会导致标本运输时间延长，从而影响结果的时效性和质量。在这项回顾性观察性研究中，研究人员评估了在澳大利亚北领地（Northern Territory, NT）两家极偏远医院实验室中，对阳性血培 ...

Idaho Technology, Inc.,(ITI) a privately held clinical diagnostics company, has received the US Food and Drug Administration (FDA) 510(k) clearance of five additional pathogens for its FilmArray ...

Rapidly screening for Ebola at U.S. hospitals has just gotten easier thanks, in part, to military-funded research. Salt Lake City-based BioFire announced over the weekend that they had received ...

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, announced today that it has commenced clinical and analytical studies to evaluate the company’s ...

FORT BELVOIR, VA--(Marketwired - November 04, 2016) - The Food and Drug Administration (FDA) approved the FilmArray ® Respiratory Panel EZ detection and diagnosis device for use in non-laboratory ...

SALT LAKE CITY, UT - Idaho Technology, Inc. (ITI) announced today that the U.S. Food and Drug Administration has issued a 510(k) clearance for the FilmArray instrument and the FilmArray Respiratory ...

On July 28, BioFire sponsored a webinar titled “The Clinical IMPACT of the FilmArray GI Panel.” The webinar featured Kimberle Chapin, MD, DABMM, FCAP, Director of Microbiology and ID Molecular ...